These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8312587)

  • 21. [Effect of tamoxifen plus octreotide on DMBA-induced mammary tumors in rats].
    Zeng XZ; Yao ZX
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):28-32. PubMed ID: 15808071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-oestrogen action in experimental breast cancer.
    Jordan VC; Naylor KE; Dix CJ; Prestwich G
    Recent Results Cancer Res; 1980; 71():30-44. PubMed ID: 6768113
    [No Abstract]   [Full Text] [Related]  

  • 23. Independent regulation of growth and steroid receptors in uterus and mammary tumors of rats.
    Janssens JP; Billiet G; Bonte J; De Loecker W
    Anticancer Res; 1983; 3(6):385-91. PubMed ID: 6230984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of tamoxifen in the induction of hormone-independent rat mammary tumors.
    Fendl KC; Zimniski SJ
    Cancer Res; 1992 Jan; 52(1):235-7. PubMed ID: 1727383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological activities of tamoxifen aziridine, an antiestrogen-based affinity label for the estrogen receptor, in vivo and in vitro.
    Wei LL; Mangel WF; Katzenellenbogen BS
    J Steroid Biochem; 1985 Dec; 23(6A):875-81. PubMed ID: 3937947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor activity of the progesterone antagonists ZK 98.299 and RU 38.486 in the hormone-dependent MXT mammary tumor model of the mouse and the DMBA- and the MNU-induced mammary tumor models of the rat.
    Schneider MR; Michna H; Nishino Y; el Etreby MF
    Eur J Cancer Clin Oncol; 1989 Apr; 25(4):691-701. PubMed ID: 2497018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of combined and sequential treatment with tamoxifen and the aromatase inhibitor vorozole on 7,12-dimethylbenz(a) anthracene-induced mammary carcinoma in the rat.
    Van Ginckel R; Janssens B; Callens M; Goeminne N; Wouters L; De Coster R
    Cancer Chemother Pharmacol; 1996; 38(1):21-8. PubMed ID: 8603447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative antioestrogen action in experimental breast cancer.
    Jordan VC
    Adv Exp Med Biol; 1981; 138():165-78. PubMed ID: 6805259
    [No Abstract]   [Full Text] [Related]  

  • 29. Sequential hormone therapy with medroxyprogesterone acetate for 7, 12-dimethylbenz [alpha] anthracene-induced rat mammary tumors.
    Iino Y; Ishikawa H; Izuo M; Takikawa H
    Jpn J Clin Oncol; 1989 Mar; 19(1):45-50. PubMed ID: 2522157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentiation of the antitumor effect of tamoxifen by combination with the antiprogestin onapristone.
    Nishino T; Ishibashi K; Hirtreiter C; Nishino Y
    J Steroid Biochem Mol Biol; 2009 Sep; 116(3-5):187-90. PubMed ID: 19500671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of tamoxifen-dependent rat mammary tumors.
    Zimniski SJ; Warren RC
    Cancer Res; 1993 Jul; 53(13):2937-9. PubMed ID: 8319198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of chemo-endocrine therapy on DMBA-induced rat mammary carcinoma].
    Yamamoto H; Morimoto T; Monden A
    Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1786-92. PubMed ID: 2512479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of tamoxifen on mammary tumors and bone in 7,12-dimethylbenz-(a)anthracene-treated rats.
    Suzuki S; Kitamura S; Sakamoto S; Sassa S; Mitamura T; Kudo H; Kuwa K; Yoshimura S; Maemura M; Nakayama T; Zhou YF; Hara Y; Shinoda H; Nagasawa H
    Anticancer Res; 1998; 18(2A):871-6. PubMed ID: 9615734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications.
    Jordan VC
    Breast Cancer Res Treat; 1983; 3 Suppl():S73-86. PubMed ID: 6423014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of In Utero Exposure to Ethinyl Estradiol on Tamoxifen Resistance and Breast Cancer Recurrence in a Preclinical Model.
    Hilakivi-Clarke L; Wärri A; Bouker KB; Zhang X; Cook KL; Jin L; Zwart A; Nguyen N; Hu R; Cruz MI; de Assis S; Wang X; Xuan J; Wang Y; Wehrenberg B; Clarke R
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27609189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Holcomb M; Safe S
    Cancer Lett; 1994 Jul; 82(1):43-7. PubMed ID: 8033067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
    J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumour activity of coumarin and 7-hydroxycoumarin against 7,12-dimethylbenz[a]anthracene-induced rat mammary carcinomas.
    Maucher A; von Angerer E
    J Cancer Res Clin Oncol; 1994; 120(8):502-4. PubMed ID: 8207051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of progesterone and R2323 on the development of dimethylbenzanthracene-induced mammary tumors.
    Kelly PA; Asselin J; Turcot-Lemay L; Labrie F; Raynaud JP
    Eur J Cancer (1965); 1979 Oct; 15(10):1243-51. PubMed ID: 230056
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of ovariectomy, tamoxifen and the combination adriamycin and 5-FU on 7,12-dimethylbenz(a)anthracene induced mammary cancer of the rat.
    Fiebig HH; Schmähl D
    Oncology; 1977; 34(2):58-61. PubMed ID: 408773
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.